Asian Phytoceuticals (Thailand) Performance
APCO Stock | THB 4.92 0.02 0.40% |
The firm shows a Beta (market volatility) of 0.28, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Asian Phytoceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Asian Phytoceuticals is expected to be smaller as well. At this point, Asian Phytoceuticals has a negative expected return of -0.19%. Please make sure to confirm Asian Phytoceuticals' standard deviation, information ratio, total risk alpha, as well as the relationship between the variance and jensen alpha , to decide if Asian Phytoceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Asian Phytoceuticals Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors. ...more
Begin Period Cash Flow | 100.2 M | |
Total Cashflows From Investing Activities | 4.9 M |
Asian |
Asian Phytoceuticals Relative Risk vs. Return Landscape
If you would invest 555.00 in Asian Phytoceuticals Public on October 8, 2024 and sell it today you would lose (63.00) from holding Asian Phytoceuticals Public or give up 11.35% of portfolio value over 90 days. Asian Phytoceuticals Public is generating negative expected returns and assumes 1.4682% volatility on return distribution over the 90 days horizon. Simply put, 13% of stocks are less volatile than Asian, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Asian Phytoceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Asian Phytoceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Asian Phytoceuticals Public, and traders can use it to determine the average amount a Asian Phytoceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1294
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | APCO |
Estimated Market Risk
1.47 actual daily | 13 87% of assets are more volatile |
Expected Return
-0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Asian Phytoceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Asian Phytoceuticals by adding Asian Phytoceuticals to a well-diversified portfolio.
Asian Phytoceuticals Fundamentals Growth
Asian Stock prices reflect investors' perceptions of the future prospects and financial health of Asian Phytoceuticals, and Asian Phytoceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Asian Stock performance.
Return On Equity | 0.13 | |||
Return On Asset | 0.08 | |||
Profit Margin | 0.31 % | |||
Operating Margin | 0.35 % | |||
Current Valuation | 2.71 B | |||
Shares Outstanding | 600 M | |||
Price To Earning | 50.00 X | |||
Price To Book | 5.01 X | |||
Price To Sales | 11.94 X | |||
Revenue | 223.35 M | |||
EBITDA | 113.31 M | |||
Cash And Equivalents | 146.48 M | |||
Cash Per Share | 0.24 X | |||
Total Debt | 43.19 M | |||
Debt To Equity | 0.08 % | |||
Book Value Per Share | 0.96 X | |||
Cash Flow From Operations | 84.4 M | |||
Earnings Per Share | 0.12 X | |||
Total Asset | 680.53 M | |||
Retained Earnings | 104 M | |||
Current Asset | 433 M | |||
Current Liabilities | 42 M | |||
About Asian Phytoceuticals Performance
By examining Asian Phytoceuticals' fundamental ratios, stakeholders can obtain critical insights into Asian Phytoceuticals' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Asian Phytoceuticals is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Asian Phytoceuticals Public Company Limited engages in the research and development, manufacture, and distribution of health and natural beauty products in Thailand. Asian Phytoceuticals Public Company Limited was founded in 1988 and is headquartered in Lamphun, Thailand. ASIAN PHYTOCEUTICALS operates under Household Personal Products classification in Thailand and is traded on Stock Exchange of Thailand.Things to note about Asian Phytoceuticals performance evaluation
Checking the ongoing alerts about Asian Phytoceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Asian Phytoceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Asian Phytoceuticals generated a negative expected return over the last 90 days | |
About 77.0% of the company shares are held by company insiders |
- Analyzing Asian Phytoceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Asian Phytoceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Asian Phytoceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Asian Phytoceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Asian Phytoceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Asian Phytoceuticals' stock. These opinions can provide insight into Asian Phytoceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Asian Stock
Asian Phytoceuticals financial ratios help investors to determine whether Asian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Asian with respect to the benefits of owning Asian Phytoceuticals security.